Elena De Mattia Selected Research

Elena De Mattia Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 09/2008
14	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 05/2009
6	Rectal Neoplasms (Rectal Cancer) 01/2022 - 04/2016
4	Inflammation (Inflammations) 04/2021 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2017
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Ovarian Epithelial Carcinoma 01/2020 - 05/2018
2	Neutropenia 01/2018 - 06/2017
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Neuroblastoma 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 04/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Liver Neoplasms (Liver Cancer) 09/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Alopecia (Baldness) 12/2014
1	Hyperplasia 12/2014
1	Osteosarcoma (Osteogenic Sarcoma) 05/2009
1	Rheumatoid Arthritis 09/2008

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 06/2022 - 01/2016
7	Irinotecan (Camptosar)FDA LinkGeneric 04/2021 - 05/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2016
6	Fluorouracil (Carac)FDA LinkGeneric 04/2021 - 05/2009
5	PlatinumIBA 01/2020 - 05/2018
5	Genetic Markers (Genetic Marker)IBA 01/2020 - 09/2017
5	Leucovorin (Folinic Acid)FDA Link 11/2019 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 05/2015
2	Pregnane X ReceptorIBA 04/2021 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 05/2015
2	Cell-Free Nucleic AcidsIBA 01/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2019
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 05/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 01/2016
2	CytokinesIBA 01/2019 - 01/2018
2	EnzymesIBA 06/2017 - 09/2008
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	palbociclibIBA 09/2020
1	ribociclibIBA 09/2020
1	abemaciclibIBA 09/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	afliberceptIBA 01/2020
1	AntigensIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	RamucirumabIBA 01/2020
1	AntibodiesIBA 01/2020
1	taxaneIBA 01/2020
1	CateninsIBA 11/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2019
1	Carboplatin (JM8)FDA LinkGeneric 10/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	Circulating Tumor DNAIBA 07/2017
1	HLA-G Antigens (HLA G)IBA 06/2017
1	3' Untranslated Regions (3' UTR)IBA 06/2017
1	MicroRNAs (MicroRNA)IBA 04/2016
1	Hepatocyte Nuclear FactorsIBA 01/2016
1	Constitutive Androstane ReceptorIBA 01/2016
1	Intergenic DNA (Junk DNA)IBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2015
1	Biological ProductsIBA 05/2015
1	Finasteride (Propecia)FDA LinkGeneric 12/2014
1	5-alpha Reductase InhibitorsIBA 12/2014
1	thiamine triphosphorate (TTP)IBA 05/2009
1	prolyl-proline (Pro-Pro)IBA 05/2009
1	arginylarginine (Arg-Arg)IBA 05/2009
1	Folic Acid AntagonistsIBA 09/2008

Therapy/Procedure

9	Therapeutics 06/2022 - 05/2015
7	Neoadjuvant Therapy 01/2022 - 05/2009
5	Drug Therapy (Chemotherapy) 04/2021 - 05/2009
3	Radiotherapy 01/2020 - 04/2016
2	Precision Medicine 07/2017 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Adjuvant Chemoradiotherapy 01/2020
1	Adjuvant Chemotherapy 10/2019
1	Liver Transplantation 08/2019
1	Immunotherapy 07/2017